Sign inJoin waitlistJoin the waitlist

PD

Pongwut Danchaivijitr

Internal Medicine

Credentials: ·

History

Internal Medicine

Research

Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
New England Journal of Medicine · 2024 · 409 citations
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results…
Journal of Clinical Oncology · 2024 · 138 citations
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
New England Journal of Medicine · 2025 · 114 citations

Joshua Bauml
5 papers
SS
Seema Sethi
5 papers
AS
Alexander Spira
4 papers
MB
Mahadi Baig
4 papers
DN
Danny Nguyen
3 papers
Saby George
3 papers
Shirish Gadgeel
3 papers
TR
Thanyanan Reungwetwattana
3 papers
AB
Abhishek Bavle
2 papers
BL
Baogang Liu
2 papers
RK
Roland Knoblauch
2 papers
SO
Sai-Hong I Ou
2 papers